$10.00 – $1,160.00
Description
OPANA IR
OPANA IR extended-release tablets are for oral use and contain oxymorphone, a semi-synthetic opioid analgesic. OPANA IR extended-release tablets are supplied in 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, and 40 mg tablet strengths for oral administration. The tablet strength describes the amount of oxymorphone hydrochloride per tablet.
The tablets contain the following inactive ingredients: hypromellose, polyethylene oxide, polyethylene glycol, α-tocopherol, citric acid, polyvinyl alcohol, titanium dioxide, macrogol and talc.
In addition, the 5 mg, 7.5 mg and 30 mg tablets contain iron oxide red. The 7.5 mg tablets contain iron oxide black, and iron oxide yellow. The 10 mg tablets contain FD&C yellow No. 6. The 20 mg tablets contain FD&C blue No. 1, FD&C yellow No. 6, and D&C yellow No. 10. The 40 mg tablets contain FD&C yellow No. 6, and D&C yellow No. 10.
WARNING : ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; NEONATAL OPIOID WITHDRAWAL SYNDROME; and INTERACTION WITH ALCOHOL
Additional information
| Type | 1mg, 2mg, 4mg, 5mg, 6mg, 8mg, 10mg, 12mg, 15mg, 20mg, 25mg, 30mg, 40mg, 50mg, 100mg, 200mg, 250mg, 275mg, 325mg, 500mg, 50amps |
|---|---|
| Units | 1 pill, 30 pills, 60 pills, 90 pills, 100 pills, 120 pills, 150 pills, 200 pills, 240 pills, 200 tabs, 300 tabs, 600 tabs, 1,000 tabs |
